EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploiting signal transduction pathways for cancer therapy: insights from natural products in preclinical models

Sarad Pawar Naik Bukke, Balakrishna Vuyyala, Chandrashekar Thalluri, Ananda Kumar Chettupalli, Neha Gupta, Muhammad Ali Abdullah Almoyad, Safa A Abdalla, Vinod Kumar Yata, Alrazi Eisa Shogar, Bayapa Reddy Narapureddy, Zohre Eftekhari, Patrick Maduabuchi Aja und 1 weitere

Frontiers in Pharmacology · 20.05.2026 · 17

DOI: 10.3389/fphar.2026.1804164 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.05.2026. Verfasst von Sarad Pawar Naik Bukke und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Pharmaceutical Technology, Kampala International University, Kampala, Uganda. Die Arbeit nennt 241 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic or epigenetic changes that lead to abnormal development of signalling through cellular pathways such as MAPK, PI3K/AKT/mTOR, Wnt/β-catenin play an important role in driving cancer. These signalling pathways control how cells grow, divide and die (apoptosis). Thus, the continued activation of these pathways represents a characteristic of oncogenesis as well as a suitable target for treatment. This review will highlight how natural products have been shown to modify the molecular pathways involved with these signalling cascades in preclinical cancer models. Data derived from an array of preclinical studies showcase how the bioactive phytochemicals that comprise these products are implemented in the form of targeting cancer cells through specific inhibition of signalling pathways, induction of apoptosis, inhibition of tumour growth and alteration of oncogenic crosstalk. Despite the significant body of evidence, there are still several limitations that exist in regards to variability between studies in terms of the methods used for validation of the mechanism by which these compounds function, differences in their bioavailability and overall robustness of those studies. Using a pathway-centered understanding of the mechanisms by which natural compounds exert their therapeutic effects will support the development of targeted phytopharmaceutical approaches and promote the integration of these therapies into evidence-based oncology practices.

Schlagwörter

Stichwörter der Autor:innen

cancer metabolismmutationsnatural productspreclinical modelssignal transduction pathways

Autor:innen und Institutionen

  • Department of Pharmaceutics and Pharmaceutical Technology, Kampala International University, Kampala, Uganda.
  • Department of Pharmacology, Gurunanak College of Pharmacy, Gurunanak Institutions Technical Campus, Hyderabad, Telangana, India.
  • Faculty of Pharmaceutical Science, Assam Down Town University (AdtU), Guwahati, Assam, India.
  • Department of Pharmaceutical Technology, School of Health and Medical Sciences, Adamas University, Barbaria, West Bengal, India.
  • Department of Pharmaceutics, Aligarh College of Pharmacy, Aligarh, Uttar Pradesh, India.
  • Department of Basic Medical Sciences, College of Applied Medical Sciences, Khamis Mushyt, King Khalid University, Abha, Saudi Arabia.

Zitieren

APA

Bukke, S. P. N., Vuyyala, B., Thalluri, C., Chettupalli, A. K., Gupta, N., Abdullah Almoyad, M. A., Abdalla, S. A., Yata, V. K., Eisa Shogar, A., Narapureddy, B. R., Eftekhari, Z., Aja, P. M., & Yadesa, T. M. (2026). Exploiting signal transduction pathways for cancer therapy: insights from natural products in preclinical models. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1804164

Vancouver

Bukke SPN, Vuyyala B, Thalluri C, Chettupalli AK, Gupta N, Abdullah Almoyad MA, et al. Exploiting signal transduction pathways for cancer therapy: insights from natural products in preclinical models. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1804164

BibTeX
@article{Bukke2026,
  author = {Bukke, Sarad Pawar Naik and Vuyyala, Balakrishna and Thalluri, Chandrashekar and Chettupalli, Ananda Kumar and Gupta, Neha and Abdullah Almoyad, Muhammad Ali and Abdalla, Safa A and Yata, Vinod Kumar and Eisa Shogar, Alrazi and Narapureddy, Bayapa Reddy and Eftekhari, Zohre and Aja, Patrick Maduabuchi and Yadesa, Tadele Mekuriya},
  title = {Exploiting signal transduction pathways for cancer therapy: insights from natural products in preclinical models},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1804164}
}
Kostenlos starten →